Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,000 | -156,000 | -147,000 | -165,000 | -189,000 |
| Depreciation Amortization | 5,000 | 26,000 | 20,000 | 14,000 | 9,000 |
| Accounts receivable | 13,000 | 15,000 | 31,000 | 34,000 | 36,000 |
| Accounts payable and accrued liabilities | 7,000 | -103,000 | -132,000 | -139,000 | -133,000 |
| Other Working Capital | 34,000 | -19,000 | 29,000 | 14,000 | 34,000 |
| Other Operating Activity | -27,000 | 44,000 | 77,000 | 94,000 | 97,000 |
| Operating Cash Flow | $89,000 | $-193,000 | $-122,000 | $-148,000 | $-146,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4,000 | -2,000 | N/A | N/A |
| Purchase Sale Intangibles | 1,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,000 | $-4,000 | $-2,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,000 | -4,000 | -3,000 | -2,000 | -1,000 |
| Common Stock Issued | N/A | 1,000 | 1,000 | 1,000 | 1,000 |
| Other Financing Activity | -2,000 | -7,000 | -5,000 | -3,000 | -2,000 |
| Financing Cash Flow | $-3,000 | $-10,000 | $-7,000 | $-4,000 | $-2,000 |
| Exchange Rate Effect | N/A | 5,000 | N/A | N/A | N/A |
| Beginning Cash Position | 858,000 | 1,060,000 | 1,060,000 | 1,060,000 | 1,060,000 |
| End Cash Position | 945,000 | 858,000 | 929,000 | 908,000 | 912,000 |
| Net Cash Flow | $87,000 | $-202,000 | $-131,000 | $-152,000 | $-148,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 89,000 | -193,000 | -122,000 | -148,000 | -146,000 |
| Capital Expenditure | N/A | -4,000 | -2,000 | N/A | N/A |
| Free Cash Flow | 89,000 | -197,000 | -124,000 | -148,000 | -146,000 |